1. V. L. Rusinov, E. N. Ulomskii, O. N. Chupakhin, and V. N. Charushin, “Azolo[5,1-c]-1,2,4-triazines as a new class of antiviral compounds,” Russ. Chem. Bull. 7 (5), 985 (2008).
2. O.N.Chupakhin, V.L.Rusinov, E.N.Ulomskii, et al., RF Patent No. 2294936 (2007).
3. S. Ya. Loginova, S. V. Borisevich, V. A. Maksimov, et al., “Studies on triazavirin’s antiviral activity in relation to flu agent A(H5N1) in a cell culture,” Antibiot. Khimioter. 52, 18 (2007).
4. I. Karpenko, S. Deev, O. Kiselev, et al., “Antiviral properties, metabolism, and pharmacokinetics of a novel azolo 1,2,4,-triazine derived inhibitor of influenza A and B virus replication,” Antimicrobial Agents Chemotherapy 54, 2017 (2010).
5. S. Ya. Loginova, S. V. Borisevich, V. L. Rusinov, et al., “Assessing the toxicity of a new domestic chemopreparation triazavirin,” Antibiot. Khimioter. 57, 8 (2012).